Search research articles
Contact Us
Filters
Showing results (21-30 of 96) with videos related to
Page
of 10
Sort By:
Deutsches Arzteblatt International
|
September 11, 2010
Substantial deficiencies
Peter Goretzki, Bernhard Lammers, Aristotelis Touloumtzidis, et al.
Anti-Cancer Drugs
|
November 2, 2010
mTOR inhibition in advanced renal cell carcinoma: which criteria should be used to evaluate therapeutic outcome?
Christoph Eimer, Holger Gerullis, Christoph Heuck, et al.
The Journal of Urology
|
June 7, 2002
Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial
Peter J Goebell, Thomas Otto, Julia Suhr, et al.
International Journal of Molecular Sciences
|
December 23, 2020
Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision?
Thorsten H Ecke, Thomas Otto, Florence Le Calvez-Kelm
International Journal of Molecular Sciences
|
May 28, 2022
Molecular Diagnostic and Prognostication Assays for the Subtyping of Urinary Bladder Cancer Are on the Way to Illuminating Our Vision
Thorsten H Ecke, Florence Le Calvez-Kelm, Thomas Otto
Histochemistry and Cell Biology
|
June 24, 2011
A proteomic approach for identification and localization of the pericellular components of chondrocytes
Zijun Zhang, Wu Jin, Jeffrey Beckett, et al.
Anti-Cancer Drugs
|
October 16, 2010
Vinflunine as second-line treatment in platin-resistant metastatic urothelial carcinoma: a review
Holger Gerullis, Thorsten Ecke, Christoph Eimer, et al.
Micromachines
|
November 15, 2018
Aluminum Patterned Electroplating from AlCl₃⁻[EMIm]Cl Ionic Liquid towards Microsystems Application
Muhammad Salman Al Farisi, Silvia Hertel, Maik Wiemer, et al.
Biomedicines
|
August 26, 2023
Functional Recovery after the Application of Amniotic Tissues and Methylene Blue during Radical Prostatectomy-A Pilot Study
Dimitri Barski, Igor Tsaur, Mihaly Boros, et al.
Cancer Chemotherapy and Pharmacology
|
September 27, 2008
Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in Germany
Holger Gerullis, Lothar Bergmann, Luise Maute, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 96) with videos related to
Sort By:
Page
of 10
Deutsches Arzteblatt International
|
September 11, 2010
Substantial deficiencies
Peter Goretzki, Bernhard Lammers, Aristotelis Touloumtzidis, et al.
Anti-Cancer Drugs
|
November 2, 2010
mTOR inhibition in advanced renal cell carcinoma: which criteria should be used to evaluate therapeutic outcome?
Christoph Eimer, Holger Gerullis, Christoph Heuck, et al.
The Journal of Urology
|
June 7, 2002
Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial
Peter J Goebell, Thomas Otto, Julia Suhr, et al.
International Journal of Molecular Sciences
|
December 23, 2020
Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision?
Thorsten H Ecke, Thomas Otto, Florence Le Calvez-Kelm
International Journal of Molecular Sciences
|
May 28, 2022
Molecular Diagnostic and Prognostication Assays for the Subtyping of Urinary Bladder Cancer Are on the Way to Illuminating Our Vision
Thorsten H Ecke, Florence Le Calvez-Kelm, Thomas Otto
Histochemistry and Cell Biology
|
June 24, 2011
A proteomic approach for identification and localization of the pericellular components of chondrocytes
Zijun Zhang, Wu Jin, Jeffrey Beckett, et al.
Anti-Cancer Drugs
|
October 16, 2010
Vinflunine as second-line treatment in platin-resistant metastatic urothelial carcinoma: a review
Holger Gerullis, Thorsten Ecke, Christoph Eimer, et al.
Micromachines
|
November 15, 2018
Aluminum Patterned Electroplating from AlCl₃⁻[EMIm]Cl Ionic Liquid towards Microsystems Application
Muhammad Salman Al Farisi, Silvia Hertel, Maik Wiemer, et al.
Biomedicines
|
August 26, 2023
Functional Recovery after the Application of Amniotic Tissues and Methylene Blue during Radical Prostatectomy-A Pilot Study
Dimitri Barski, Igor Tsaur, Mihaly Boros, et al.
Cancer Chemotherapy and Pharmacology
|
September 27, 2008
Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in Germany
Holger Gerullis, Lothar Bergmann, Luise Maute, et al.
Page
of 10